Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Edwards Lifesciences Nordic AB
AB
Active
Org 5565933818
Södra Långgatan 25, 211 44
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2000
36 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Edwards Lifesciences Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
151M
302M
454M
605M
430M
2020
450M
2021
493M
2022
520M
2023
526M
2024
EBITDA
SEK millions
0M
12M
23M
35M
46M
17M
2020
16M
2021
25M
2022
22M
2023
40M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
430 469
449 607
492 949
519 608
526 131
Staff expenses
—
—
—
—
—
EBITDA
16 858
16 140
25 369
22 416
40 354
Depreciation & amort.
−440
−310
−213
−153
−188
EBIT
16 418
15 830
25 156
22 263
40 166
Net financials
−1 027
−547
−907
−2 187
−274
Profit before tax
15 392
15 283
24 249
20 553
39 895
Tax
−3 352
−3 455
−5 374
−4 674
−8 649
Net profit
12 040
11 828
18 875
15 879
31 246
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
144 145
155 021
178 305
163 767
173 634
Equity
38 610
51 706
72 748
87 036
118 432
Long-term debt
0
0
0
0
0
Short-term debt
100 359
96 155
102 117
73 369
51 827
Total debt
100 359
96 155
102 117
73 369
51 827
Financial ratios
5-year trend
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
2020
2024
Equity ratio
68.2%
This company
38.2%
Market median
+79% vs market
2020
2024
Return on equity
26.4%
This company
18.4%
Market median
+43% vs market
2020
2024
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
2020
2024
Asset turnover
3.03×
This company
1.12×
Market median
+171% vs market
2020
2024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Edwards Lifesciences Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
